Short description:
Radiopharmaceuticals
Drug notes:
Contact us to add description: recruit@workinbiotech.com
Long description:
Alpha-9 Theranostics is a clinical stage company developing highly selective, peptide-based radiopharmaceuticals for cancer treatment. Their treatments are developed with a binder, linker, chelator, and radioisotope, giving them high selectivity for delivering radiation to cancer cells with minimal off-target effects. Their developed molecules are optimized for imaging, dosimetry, and therapy studies to evaluate the tumor uptake and dose delivery, as well as determine the optimal patient population. Alpha-9 Theranostics was founded in 2019 by researchers in British Columbia to improve the lives of people with metastatic cancers. Alpha-9 Theranostics’ new research facility in Vancouver was completed in 2023, housing chemistry, biology, and radiochemistry R&D teams to accelerate their discovery efforts.
Jobs:
Vice President, Clinical Operations San Francisco, California, Stati Uniti d'America|18 days ago
Director, Clinical Operations San Francisco, California, Stati Uniti d'America|18 days ago
Vice President, Clinical Development San Francisco, California, Stati Uniti d'America|18 days ago
Scientist, Chemistry, Peptides Vancouver, Columbia Britannica, Canada|22 days ago
Senior Scientist, CMC Radiochemistry Vancouver, Columbia Britannica, Canada|23 days ago
Scientist, Translational Biology Vancouver, Columbia Britannica, Canada|23 days ago